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days post-fertilization (dpf). Chemicals eliciting behav-
ioral responses were also mapped against external HTS 
in vitro results to identify specific molecular targets and 
neurosignalling pathways. We found that, as an integra-
tive measure of normal development, significant altera-
tions in movement highlighted active chemicals repre-
senting several modes of action. These early behavioral 
responses were predictive for 17 specific developmental 
abnormalities and mortality measured at 5 dpf, often at 
lower (i.e., more potent) concentrations than those at 
which morphological effects were observed. Therefore, 
this system can provide rapid characterization of chemi-
cal-elicited behavioral responses at an early developmen-
tal stage that are predictive of observable adverse effects 
later in life.
Keywords Developmental neurotoxicology · Alternative 
testing · Chemical biology · Behavior · Zebrafish · High-
throughput screening · Bioinformatics · Data integration · 
ToxCast · Bioactivity
Introduction
There are tens of thousands of manufactured chemicals 
currently in commerce, each with varying production vol-
umes, use profiles, and potential for environmental release, 
persistence, and bioaccumulation. Comprehensive data 
on the human and environmental health hazards of these 
chemicals remain elusive, ranging from sparse to nonexist-
ent. High-throughput screening (HTS) efforts such as Tox-
Cast™ and Tox21™ were conceived to begin addressing 
this data need by applying new in vitro assay technologies 
to speed the pace of chemical testing (Collins et al. 2008; 
Judson et al. 2010).
Abstract New strategies are needed to address the data 
gap between the bioactivity of chemicals in the environ-
ment versus existing hazard information. We address 
whether a high-throughput screening (HTS) system using 
a vertebrate organism (embryonic zebrafish) can charac-
terize chemical-elicited behavioral responses at an early, 
24 hours post-fertilization (hpf) stage that predict terato-
genic consequences at a later developmental stage. The 
system was used to generate full concentration–response 
behavioral profiles at 24 hpf across 1060 ToxCast™ 
chemicals. Detailed, morphological evaluation of all indi-
viduals was performed as experimental follow-up at 5 
Electronic supplementary material The online version of this 
article (doi:10.1007/s00204-015-1554-1) contains supplementary 
material, which is available to authorized users.
 * Robert L. Tanguay 
 robert.tanguay@oregonstate.edu
 David M. Reif 
 dmreif@ncsu.edu
 Lisa Truong 
 lisa.truong@oregonstate.edu
 David Mandrell 
 mandrelld@gmail.com
 Skylar Marvel 
 swmarvel@ncsu.edu
 Guozhu Zhang 
 gzhang6@ncsu.edu
1 Bioinformatics Research Center, Department of Biological 
Sciences, North Carolina State University, Raleigh, NC, USA
2 Sinnhuber Aquatic Research Laboratory, Department 
of Environmental and Molecular Toxicology, Environmental 
Health Sciences Center, Oregon State University, 28645 East 
Highway 34, Corvallis, OR 97333, USA
1460 Arch Toxicol (2016) 90:1459–1470
1 3
While simple in vitro screening assays are useful for 
probing targeted receptor–ligand interactions, these screens 
fail to take into account the complexity of the vertebrate 
nervous system and will miss chemicals that modify nerv-
ous system function in novel ways. A phenotype-based 
screen is needed to identify developmental neuromodula-
tory compounds in the absence of specific targets (Burns 
et al. 2013; Selderslaghs et al. 2013). Designing in vivo 
phenotypic screens in a high-throughput manner would 
provide the ability to discover complex behavioral phe-
notypes using whole organisms, where the full gamut of 
coordinated events leading to nervous system development 
occurs, including cellular differentiation, proliferation, 
migration, synapse formation, and apoptosis (Makris et al. 
2009; Padilla et al. 2012; Sanes et al. 2005; Truong et al. 
2014).
Zebrafish (Danio rerio) is a prolific, small, com-
plex organism that shares a highly conserved anatomy 
and physiology with all vertebrates (Howe et al. 2013). 
Importantly, the critical processes of zebrafish neurode-
velopment are homologous to those in humans (Tro-
pepe and Sive 2003). Early in zebrafish embryogenesis 
[roughly 19–29 hours post-fertilization (hpf)], spontane-
ous tail contractions occur as the muscles in this region 
are innervated (Kimmel et al. 1995). This spontaneous 
behavior is sensitive to high-intensity light perturba-
tion via photoreceptors in the developing hindbrain 
and has been designated as the photomotor response 
(PMR) (Kokel et al. 2013). The normal PMR is sensi-
tive to chemical perturbation and amenable to screen-
ing for behavior-modifying compounds (Raftery et al. 
2014). In Kokel et al. (2010), the authors developed 
behavioral barcodes that classified small molecules 
from six libraries (primarily pharmaceuticals and candi-
date pharma-like chemical entities) into related clusters 
according to PMR of pooled embryo samples at a single 
concentration.
Here, we report HTS results that characterize the diverse 
ToxCast Phase-I and Phase-II libraries (1060 unique 
chemicals) using a five-point, log concentration range 
(from 6.4 nM to 64 µM) for each chemical. These results 
were generated using single-embryo wells with 32 repli-
cate samples at each concentration, where all individuals 
are followed up by morphological assessments at 120 hpf 
(5 dpf). Thus, our assay system allows the characteriza-
tion of behavioral changes across chemical concentrations, 
provides increased detection power and reliability of indi-
vidual endpoint measurements, and quantifies developmen-
tal consequences of behavioral aberrations measured early 
in development. As additional follow-up, we mapped our 
results to external data to discover associations between 




The ToxCast Phase-I and Phase-II chemical libraries were 
provided by the US EPA National Center for Computa-
tional Toxicology (NCCT). There were 1060 unique chemi-
cals from various sources. Stock solutions of all the chemi-
cals were provided at a 20-mM concentration in 100 % 
dimethyl sulfoxide (DMSO) in multiple 96-well plates. 
More details regarding the chemical library and quality 
control can be found at http://www.epa.gov/NCCT/tox-
cast/chemicals.html. Chemical dilutions (1:10) for expo-
sure plates were made using DMSO and standard embryo 
medium (EM) (Westerfield 2000) to achieve a concentra-
tion range of 0.064–640 µM with a DMSO concentration 
of 6.4 %. All dilution plates were sealed and then stored at 
−20 °C until used for exposure.
Experimental design
Adult wild-type zebrafish (Tropical 5D) were raised in 
the Sinnhuber Aquatic Research Laboratory at Oregon 
State University, Corvallis, Oregon. Groups of 1000 adult 
zebrafish were housed in 100 gallon tanks kept at stand-
ard laboratory conditions of 28 °C on a 14-h light/10-h 
dark photoperiod in fish water (reverse osmosis water sup-
plemented with Instant Ocean™, a commercially avail-
able salt). Zebrafish were spawned, and embryos were col-
lected and staged according to Kimmel et al. (Kimmel et al. 
1995). At 4 hpf, embryos were dechorionated using pro-
nase (63.6 mg/ml, >3.5 U/mg, Sigma-Aldrich: P5147) by 
a custom automated dechorionator (Mandrell et al. 2012).
Using the automated embryo placement systems (AEPS) 
previously described (Mandrell et al. 2012), 6 hpf decho-
rionated embryos were individually placed into a 96-well 
plate (1 embryo per well) prefilled with 90 µL of EM. Ten 
microliters of chemical from dilution plate 2 was added to 
each row of two 96-well plates. A final DMSO concentra-
tion was maintained throughout the experiment of 0.64 % 
(v/v). For each concentration, a total of 32 embryos were 
exposed. All exposure plates were sealed using parafilm 
to prevent evaporation and wrapped in aluminum foil to 
prevent light exposure. During this development period, 
zebrafish embryos are able to adapt to the dark and develop 
normally (Kokel et al. 2013). Exposed plates were stored 
in 28 °C incubator, and embryos were statically exposed 
until 120 hpf (5 dpf). At 24 hpf, embryos were assessed 
for PMR (as described below) and evaluated for mortal-
ity (MO24 = mortality at 24 hpf) (Truong et al. 2011). At 
5 dpf, embryos were assessed for 17 morphological end-
points and collected in Zebrafish Acquisition and Analysis 
Program (ZAAP) (Truong et al. 2014).
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Embryos were assessed for PMR using the custom-built 
Photomotor Response Analysis Tool (PRAT). The system 
uses a Prosilica GX3300 (Allied Vision, Stadtroda, Ger-
many) with near infrared (NIR) band-pass filter to remove 
any influence of stimulus light. The lens is double telecen-
tric (Navitar, Rochester, New York), mounted in an inverted 
manner beneath the plate holder to allow for imaging with 
minimum distortion and perspective interference. Imaging 
illumination is accomplished with a NIR (850 nm) Back-
light (Smart Vision Lights, Muskegon, MI). PMR stimulus 
light is from two white L300 Linear Lights (Smart Vision 
Lights, Muskegon, MI). The system is controlled by cus-
tom hardware for timing the high-intensity light stimuli and 
system backlight. Video recording began immediately prior 
to light cycle initiation and captures 850 frames of digital 
video, recorded at 17 frames s-1. The light cycle consists 
of 30 s (sec) of background (prior to the first light pulse), 
a short pulse of light, 9 s before the next pulse, a second 
pulse of light, and then 10 s of dark.
To analyze the videos, a custom MATLAB program 
(Mathworks, Natick, MA) was used to compute a move-
ment index for each frame stamp (the pixel differences 
between frames). The program output was processed using 
custom R scripts (R Core Team 2014) to discard the lag 
time that occurs between when the video recording was 
initiated and the light cycle begins/ends. A time stamp was 
created from the frame stamp by taking the first stamp after 
the recording started, setting that as 0 s, and then taking the 
floor of the sequential frame stamps.
Quality control, identifying outliers, and quantifying 
expected responses
All subsequent analysis began with the processed data 
described above and was implemented using the R lan-
guage (R Core Team 2014). First, we checked for aber-
rant background responses in individual plates and chemi-
cal sets by comparison with global patterns across all 
experiments. A total of 66 chemical sets (approximately 
6 %) were rerun in full (both plates) after evaluation of 
the controls to identify those lacking post-light excitatory 
responses via either background (pre-light) peak movement 
index higher than the excitatory (post-light) peak, or no dif-
ference in movement from background to excitatory inter-
val. After confirming lack of batch effects, these rerun data 
overwrote the original data in the results reported here.
Next, we removed wells annotated as having embryo 
mortality (MO24), as described in Experimental Design. 
For the analysis, the recorded periods were truncated to 
assure equivalence in recorded experimental period for all 
chemicals. Outlier detection was applied independently 
to each chemical concentration and time point combina-
tion. Movement values between the top 80–99 % quantiles 
(ignoring zero-movement values) were fit by a shifted 
gamma distribution using a maximum likelihood approach. 
An outlier was then defined as any movement value with a 
Bonferroni-corrected p value <0.05/n, where n is the num-
ber of movement values used to fit the model. This strin-
gent cutoff criterion was chosen to remove outliers while 
preserving natural variation.
Additionally, we implemented a filter based upon depar-
ture from expected responses across all negative control 
(i.e., DMSO-only) wells. This filter prevents any signifi-
cant calls from being made when the control fish are less 
responsive than expected. The peak-mean movement val-
ues within the excitatory interval were fit to a gamma dis-
tribution using a maximum likelihood approach, where a 
peak-mean movement value was defined as the maximum 
mean movement value of exposed fish for each chemical 
within that interval. Significance calls were prevented for 
any chemical with a peak-mean movement p value <0.05.
Analysis of chemical‑associated activity
Our analysis was designed to account for the unusual dis-
tributional properties of developmentally normal, spontane-
ous movement responses, and avoid bias toward one side of 
a bidirectional behavioral response where either direction 
could represent aberrant health effects of a chemical. Post-
filtering (described in the previous section), the remaining 
experimental period (21–48 s) was subdivided according 
to light pulses: background (B) = 9 s prior to first pulse 
(21–29 s); pulse1 = first pulse of light; latency1 = 1 s 
immediately following first pulse; excitatory (E) = 8 s 
between light pulse (32–39 s); pulse2 = second light pulse; 
latency2 = 1 s immediately following second pulse; refrac-
tory (R) = 7 s after second pulse (42–48 s).
The statistical analysis of activity considered only the 
background (B), excitatory (E), and refractory (R) inter-
vals. The overall pattern of activity within each B, E, or R 
interval was compared to that interval’s negative control 
(0 μM) activity using a combination of percent change 
(−50 % change from control for hypoactivity; 75 % change 
from control for hyperactivity) and a Kolmogorov–Smirnov 
test (Bonferroni-corrected p value threshold = 0.05/5 con-
centrations = 0.01). The percent change thresholds for 
hypo- and hyperactivity were parameterized so that the 
distributions of negative control responses were equivalent 
across activity-associated chemicals (i.e., “hits”). The Kol-
mogorov–Smirnov test compared the empirical cumulative 
distribution function (eCDF) between the chemical-treated 
samples and the negative control. For each chemical con-
centration set of n = 32 embryo wells, the treated wells 
were compared to vehicle (negative control) wells across 
two replicate plates for each chemical. This permits scal-
ability of the procedure to custom batches of chemicals 
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in either new experiments or retests (see “Quality control, 
identifying outliers and quantifying expected responses”).
The 5 dpf developmental morphology data, as described 
in Truong et al. (2014), were used to estimate the predictive 
value of this early, 24 hpf response. We modified the cal-
culation of statistical significance from that paper in order 
to account for changing proportions from censored wells. 
Fisher’s exact test was used to define a morphology lowest 
effect level (LEL) if the incidence of the 5 dpf morphological 
endpoints were significantly different between the control fish 
and a concentration of chemical. Fish indicated as MO24 or 
5 dpf mortality (MORT) were not included in the count data 
used in the test. The relative risk (RR) associating movement 
at 24 hpf (early effects) and the morphological endpoints 
measured at 5 dpf (later effects) was estimated from the num-
ber of chemicals positive for both early and late effects (true 
positive = TP); positive for early effects but negative for later 
effects (false positive = FP); negative for early effects but 
positive for later effects (false negative = FN); and negative 










Data were collected from embryos exposed to each of 1060 
ToxCast Phase-I and Phase-II chemicals (see “Chemicals”). 
The experimental design in Fig. 1 illustrates dechorion-
ated embryonic zebrafish exposed to vehicle control plus 
five concentrations at 6 hpf, a photomotor response (PMR) 
assay at 24 hpf, and evaluation of 17 developmental mal-
formation endpoints at 5 dpf. The response to the 24 hpf 
behavioral assay was interrogated, and movement profiles 
were established that characterized bidirectional responses 
to chemical exposure across a common five-point concen-
tration range (see “Methods”). Representative hypo-/hyper-
activity-associated chemical profiles are shown in Fig. 2. 
Full concentration response results for all chemicals are 
given in Supplemental Table 1.
Global patterns of response and reliability
While individual sample (embryo) wells displayed vari-
ability in the magnitude of response, by considering the 
nonparametric distribution of all samples, a remarkably 
consistent pattern of activity emerged in control wells (see 
Fertilization 6 h 24 h (1 day) 
Chemical Exposure 
























































Fig. 1  Experimental design. For each of 1060 chemicals, the chemi-
cal exposure at 6 hpf saw one of 5 concentrations of a given chemical 
added to individual embryo wells in 96-well plates. At 24 hpf, plates 
were subjected to light pulse exposure (at 30 s and 40 s) for the PMR 
assay. Movement was recorded across the short (<1 min) interval and 
then converted into the concentration–response profile shown under 
behavioral assessment. At 5 dpf, plates were assessed for specific 
developmental malformations, an example of which is shown under 
developmental assessment
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leftmost plots in Fig. 2). The background (B) interval was 
characterized by basal activity with moderate variance but 
absence of distinct activity peaks. The excitatory (E) inter-
val displayed a single peak of hyperactivity with high vari-
ability as to the absolute peak movement and then imme-
diately dropped to a movement level below that of B. The 
refractory (R) interval was characterized by a significant 
drop in movement compared to B, with inactivity lasting 
beyond the time interval measured.
The 9 sets of embedded chemical triplicate (each 
sourced separately) included in the data were used to assess 
reliability of activity calls. Using the same metric of assay 
concordance estimated for the ToxCast™ in vitro systems 
(http://epa.gov/ncct/toxcast/data.html), the reliability of 
activity calls was 89 %. For example, all three replicate 
sets for Allethrin exhibited the extremely rare refractory 
(R) hyperactivity response (observed in less than 1 % of all 
chemicals) at the same 64-μM concentration. Therefore, 
we concluded that the reliability was sufficient to collapse 
the embedded triplicate and report subsequent results with 
respect to the set of 1,060 unique substances.
In total, 296 chemicals showed statistically significant 
activity in at least one interval (Supplemental Table 1 and 
Fig. 3). Of these significant chemicals, considering the low-
est effect level (LEL) as the most potent (i.e., smallest con-
centration of chemical) response within a given time inter-
val across all concentrations, there were 148 hypoactive 
and 5 hyperactive in B, 260 hypoactive and 18 hyperactive 
in E, and 7 hyperactive in R. The LEL overlap across inter-
vals consisted of 12 out of 153 that were unique to B, 136 
of 278 that were unique to E, and 6 of 7 that were unique 
to R. Beyond totals, considering the LEL as the most 
potent response across time intervals for a given chemical 
revealed the E interval as most sensitive in terms of detect-
ing the most chemicals (171) at the lowest concentration. 
The B interval was the most sensitive for only 13 chemi-
cals, and although rare, the 7 chemicals hyperactive within 
the R interval defined the LEL across intervals. These 
results indicate that each experimental period is differen-
tially informative and that light-elicited behavioral changes 
in E tend to be most sensitive to chemical perturbation.
The LEL was chosen as the unit of analysis within each 
interval for several reasons illustrated by Fig. 3. The most 
sensitive effect (i.e., defining an LEL as the most potent 
chemical concentration associated with a significant effect) 
should be the most specific behavioral indicator. While 
hypoactive behavioral effects were observed for some 
chemicals at higher concentrations than those at which a 
hyperactive LEL was observed, zero chemicals across this 
diverse 1060 set caused significant reduction in movement 
followed by hyperactivity at a higher concentration. This 
point is extremely important when considering a behav-
ioral endpoint that can take on three states (i.e., hyperac-
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Fig. 2  Detecting significant alterations in movement. The top panel 
shows movement (vertical axis, dimensionless index) versus time 
(horizontal axis, in sec) across all concentrations, increasing from left 
(control wells in the absence of chemical) to right (highest concen-
tration = 64 µM). The vertical red lines indicate the timing of light 
pulses. Each circle represents movement at a given time for a repli-
cate embryo well (32 replicates per chemical concentration combi-
nation). A locally weighted regression (LOESS) fit was plotted as a 
solid black line. The experimental intervals modeled in the behavioral 
analysis included background (B), excitatory (E), and refractory (R). 
Red asterisks denote significant responses for a particular concentra-
tion–time interval combination. The hyperactivity example chemi-
cal shown, tributyltin chloride, had an estimated lowest effect levels 
(LEL) of 0.064 μM for hyperactivity within the E interval and an 
LEL of 0.64 μM for hypoactivity within the B interval. The hypo-
activity example chemical shown, abamectin, had estimated LELs of 
6.4 μM in B and 0.64 μM in E (color figure online)
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Fig. 3  Response patterns for all chemicals across concentrations. In 
part A, movement versus time is plotted for all concentrations from 
left (control wells in the absence of chemical) to right (highest con-
centration) for a single chemical (abamectin, as in Fig. 2). Red aster-
isks denote significant responses for a particular concentration–time 
interval combination. In part B, the concentration–response data for 
the given chemical have been overlaid as a locally weighted regres-
sion (LOESS) fit, plotted with line thickness proportional to con-
centration of chemical. The LOESS fit for control embryos (wells in 
the absence of chemical) is plotted as a solid black line. In part C, 
the significant responses are collapsed into a heatmap vector (row) 
colored according to hyperactivity (orange) or hypoactivity (blue) at 
a given concentration and time interval. For the given chemical, only 
hypoactive significant responses were observed. In part D, the signifi-
cant response vector for the given chemical is added as a single row 
in a heatmap for all chemicals (one chemical per row). The colorless 
portion of the heatmap represents the 764 chemicals without signifi-
cant activity. In part E, the portion of the heatmap containing the 296 
chemicals showing significant activity within at least one interval has 
been expanded (color figure online)
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dose–response may appear “non-monotonic” with respect 
to absolute movement. For example, a low-dose hyperac-
tive response may trend toward hypoactivity at higher 
doses (e.g., tributyltin chloride or butylparaben), but the 
intermediate doses may be observed to pass through an 
apparent “no effect” response. This finding highlights the 
importance of a concentration–response design in assess-
ing behavior, where a single concentration may happen to 
coincide with the point at which a response is neither sig-
nificantly hyper- nor hypoactive as it transitions from sig-
nificant hyperactivity at lower concentrations on the way to 
hypoactivity at higher concentrations. Moreover, because 
many of these high-concentration movement reductions 
were associated with mortality, it is likely that these effects 
were indicative of toxicity pathways leading to death.
Considering hypo- or hyperactivity LELs defined over 
the light intervals specified, we classified chemicals as 
eliciting light-independent movement alterations, light-
dependent movement alterations (i.e., PMR specific), or 
indistinguishable from the observed data. The concentra-
tion–response profiles allowed us to infer light dependence 
for chemicals eliciting a post-light response (in E or R) at 
a concentration more potent than that at which significant 
(or absence of) B responses were observed. We found that 
178 chemicals met this criterion of light-dependent move-
ment alteration as the most sensitive effect (Supplemental 
Table 2). The LELs were distributed as 25 hyperactive and 
153 hypoactive. The chemicals included several conazoles, 
thiocarbamates, metals, phthalates, toluenes, and the andro-
genic steroids 17-methyltestosterone, 17beta-trenbolone, 
4-androstene-317-dione, and 5alpha-dihydrotestosterone.
In addition to evaluating signature profiles, we assessed 
the association of a chemical’s tendency to partition 
between hydrophobic and hydrophilic phases (LogP) with 
its ability to impact nervous system development in the 
PMR assay. Chemicals with higher LogP should be more 
permeable across biological membranes. However, as with 
a recent meta-analysis of zebrafish results across laborato-
ries and experimental designs (Ducharme et al. 2013), we 
did not find significant evidence of LogP trending with 
effects across all chemicals in this behavioral assay. The 
absence of observed correlation may be due in part to the 
dechorionation step prior to chemical exposure, which 
facilitates uptake.
Diverse modes of action are detectable by this assay
Examining chemicals having known bioactivity that dis-
played particular response patterns across intervals sug-
gests that several modes of action are detectable by this 
assay, including direct binding to neurological elements, 
indirect signaling disruption, muscular contractile disregu-
lation, and disruption of normal structural development. 
For example, the PMR assay was adept at detecting insec-
ticides shown to target acetylcholinesterase, such as mala-
thion (Cook et al. 2005) and all three forms of chlorpyrifos 
tested (Levin et al. 2003; Li et al. 2014; Yang et al. 2011). 
Moreover, this assay corrected identified the oxon metab-
olite of chlorpyrifos as more potent than the parent com-
pound (6.4 vs. 64 μM, respectively). The thiocarbamate 
pesticides cycloate, dazomet, disulfiram, molinate, sodium 
dimethyldithiocarbamate, thiobencarb, thiram, and ver-
nolate, known to cause notochord malformation resulting 
in neuronal and muscular disruptions, were identified by 
this assay but not associated with mortality (Haendel et al. 
2004; Tilton et al. 2006; Tilton and Tanguay 2008). Not 
only does the PMR assay detect strictly nervous system 
or canonical neurotoxic modes of action, but it also iden-
tifies chemicals disrupting gross structural development, 
such as tributyltin chloride, tributyltin methacrylate, and 
triphenyltin hydroxide, which showed behavioral effects 
at concentrations lower than those at which morphological 
abnormalities were observed (McGinnis and Crivello 2011; 
Micael et al. 2007).
We also find several examples of chemical structural 
classes related to activity. None of the eight compounds 
from the thiophosphate alkyl subclass (tribufos, chloreth-
oxyfos, disulfoton, ethion, phorate, fosthiazate, terbufos, 
ethoprop) were active at 24 hpf. However, eighteen other 
thiophosphates, including fenitrothion, fenthion, methyl 
parathion, parathion (metabolized in vivo to Paraoxon), 
azinphos-methyl (gusathion), malathion, and methidathion, 
were all hypoactive in the post-light E interval, presumably 
via known acetylcholinesterase-related mechanisms. All 
five strobins included in this chemical set showed evidence 
of hypoactivity, with fluoxastrobin, trifloxystrobin, pyra-
clostrobin, and picoxystrobin having significant effects in 
the B and E intervals, and azoxystrobin’s otherwise signifi-
cant hypoactivity censored by excess MO24 (mortality at 
24 hpf). This may represent a mitochondrial adverse out-
come pathway (AOP), where these fungicides act to inhibit 
the respiratory chain at the level of complex III (Bartlett 
et al. 2002). Indeed, beyond these strobins, other chemicals 
with known mitochondrial targets, such as rotenone (Ai 
et al. 2014; Navarro et al. 2010), pyridaben (Navarro et al. 
2010), and fenpyroximate (Z,E) (Shiraishi et al. 2012) dis-
played hypoactive responses.
We found that significant movement within the refrac-
tory interval was very rare, with only seven chemicals 
showing hyperactivity: hexaconazole, carbofuran, cyper-
methrin, methomyl, prallethrin, S-bioallethrin, and alle-
thrin. The response patterns suggested delayed recovery 
from light-stimulated excitation or sustained hyperactivity 
with disruption of the stereotypical photomotor response. 
These chemicals include 4 pyrethroids known to affect ion 
channels, a known neurotoxic triazole organophosphate 
1466 Arch Toxicol (2016) 90:1459–1470
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(hexaconazole), and two carbamates (methomyl and carbo-
furan, which was once prescribed as an anxiety treatment 
in humans) known to affect acetylcholinesterase activity 
(Ensibi et al. 2014).
The most potent hypoactive chemicals at 24 hpf 
(LEL ≤ 0.064 μL) were emamectin benzoate (Carmichael 
et al. 2013), rotenone (Swarnkar et al. 2011), triphenyltin 
hydroxide (Zsombok et al. 1997), thiram (Lee and Peters 
1976), mercuric chloride (Yasutake et al. 2010), dapsone 
(Waldinger et al. 1984), and fluconazole (van Schie et al. 
2011). Although all of these compounds have been impli-
cated in nervous system perturbations related to neuromus-
cular dysfunction, this behavioral assay detected diverse 
mechanisms of action. For example, rotenone is a pesticide 
that promotes Parkinson-like behavior upon exposure by 
inhibiting mitochondrial complex I (Bretaud et al. 2004), 
while emamectin benzoate interferes with γ-aminobutyric 
acid (GABA)-gated ion channels in the nervous system 
(Carmichael et al. 2013).
External data integration to identify specific molecular 
targets
To investigate whether chemicals associated with neurobe-
havioral phenotypes in our data were associated with bio-
logical pathways that manifest in neuroactive responses, we 
performed a statistical enrichment analysis of our zebrafish 
24 hpf behavioral (in vivo) data in conjunction with bio-
chemical assay (in vitro) results from (Sipes et al. 2013), 
where the ToxCast Phase-I and Phase-II chemicals were 
screened across 331 cell-free enzymatic and ligand-binding 
assay targets. The analysis considered statistical enrich-
ment (Fisher’s exact test p < 0.05 and odds ratios >1) of 
chemical “hits” in the 24 hpf behavioral results associated 
with individual in vitro assays (e.g., Novascreen human 
peripheral-type benzodiazepine receptor-binding assay). 
We also performed the same enrichment analysis in associ-
ation with high-level assay groupings from Table 1 in Sipes 
et al. which aggregated assays into functional groupings 
such as aminergic G-protein coupled receptor binding (32 
assays), ion channel binding (7 assays), or cholinesterase 
enzyme inhibition (3 assays).
Considering the full concentration–response profile to 
define light-dependent effects (see Supplemental Table 2 
as described earlier), chemicals eliciting light-dependent 
LELs were associated with hits on assay groups of nuclear 
receptors, transporters, CYPs, ion channels, and aminer-
gic GPCRs. The individual assays associated with light-
dependent LELs were the binding assays probing VMAT2 
(vesicular monoamine transporter), PBR (peripheral ben-
zodiazepine receptor or TSPO), DAT (dopamine trans-
porter), NET (norepinephrine transporter), PXR (pregnane-
X receptor), PR (progesterone receptor), AR (androgen 
receptor), and CAR (constitutive androstane receptor), as 
well as enzymatic inhibition assays for MAOB (mono-
amine oxidase B) and several CYPs (human CYP19A1, 
CYP1A1, CYP2B6, CYP1A2, CYP2D6). This behavioral 
assay identified light-dependent hypoactivity for 15 of the 
16 chemicals that were hits in the external, in vitro MAOB 
assay.
We also considered more general response prototypes 
of hyper- or hypoactivity within each experimental light 
interval as chemical subsets for mapping against the tar-
geted, in vitro results. These response prototypes were 
defined according to LELs within intervals. For example, 
123 chemicals displayed the (B,E,R) prototype = (−1, 
−1, 0), corresponding to hypoactivity LELs within both 
the background and excitatory intervals. We found that 
this prototype indicating general hypoactivity was asso-
ciated (p < 0.05) with many of the same assays as the 
light-dependent chemicals, plus assays for 5-HT (seroto-
nin receptor) and several opioid receptors. Thus, chemi-
cals eliciting abnormal behavioral responses at 24 hpf in 
zebrafish are enriched for activity within in vitro assays 
probing genes that have known roles in canonical neurolog-
ical signaling. Variation in these genes, such as monoamine 
oxidase A (MAOA), has been associated with a variety of 
psychiatric traits and sensitivity to chemical therapeutics 
(Ziermans et al. 2012).
On the flip side, statistically significant in vitro assay 
associations with negative chemicals, i.e., those with pro-
totype = (0, 0, 0), had “protective” odds ratios (Fisher’s 
exact test p < 0.05 and odds ratios <1). In this context, the 
interpretation of a significant odds ratio <1 is that the com-
pounds inactive in this behavioral assay were less likely to 
“hit” the given targeted assays. The in vitro assay groups 
fitting this criterion included cholinesterases, nuclear 
receptors, transporters, CYPs, ion channels, and aminergic 
GPCRs. Thus, chemicals that were negative in this 24 hpf 
behavioral assay displayed essentially the inverse relation-
ship with in vitro assays targeting plausible neuroactivity 
pathways. Importantly, there were no significant, positive 
odds ratios that associated the (0, 0, 0) behavioral prototype 
with any individual assay or assay group from Sipes et al.
Predictive power of 24 hpf behavioral results
Taking advantage of the multi-scale nature of the phe-
notypic measurements collected, we integrated across 
24 hpf behavior and follow-up 5 dpf development end-
point to understand relationships amongst endpoint 
types. Figure 4 shows the prospective association rela-
tive risk (RR) between hypoactive movement at 24 hpf 
and the morphological endpoints measured at 5 dpf. We 
found that these early behavioral responses were predic-
tive (RR p value <0.05) of 17 specific developmental 
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abnormalities—including 18 of 22 chemicals causing noto-
chord defects—and mortality measured at 5 dpf. Moreo-
ver, many 24 hpf behavioral LELs were more potent than 
those for gross morphological effects, such as the hypoac-
tive LELs for all three neurotoxicant avermectins tested: 
abamectin, milbemectin, and emamectin benzoate (Luma-
ret et al. 2012). Additional value added from this assay is 
exemplified by responses such as that of thiram (a mem-
ber of the ethylene bisdithiocarbamate class and the most 
potent 24 hpf hypoactive chemical), which was not associ-
ated with mortality at either 24 hpf or 5 dpf, though specific 
developmental defects (including notochord malformation) 
were observed at 5 dpf (see Fig. 4).
While confidence bands for the lower-incidence end-
points in Fig. 4 are wider than those for more common 5 
dpf endpoints, all endpoint-wise RR for chemicals eliciting 
hypoactive responses in B or E is statistically significant in 
the positive direction (i.e., aberrant behavior at 24 hpf is 
associated with higher risk of developmental abnormalities 
at 5 dpf). Furthermore, the positive predictive values (PPV) 
of hypoactivity results for any 5 dpf endpoint, defined as 
the fraction of chemicals causing 24 hpf hypoactivity that 
caused at least one specific developmental abnormality at 
5 dpf, were 90, 66, and 71 % for the B, E, and R intervals, 
respectively.
Discussion
As an integrative measure of normal development, signifi-
cant alterations in movement highlight chemicals repre-
senting several modes of action. Evaluating the photomotor 
MORT: mortality 
YSE: yolk sac edema  
AXIS: bent body axis  
EYE: eye  
SNOU: snout  
JAW: jaw  
OTIC: otic  
PE: pericardial edema  
BRAI: brain  
SOMI: somite  
PFIN: pectoral fin  
CFIN: caudal fin  
PIG: pigmentation  
CIRC: circulation  
TRUN: trunk length  
SWIM: swim bladder  
NC: notochord distortion  
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Fig. 4  Predictive power of 24 hpf behavioral data. For chemicals 
eliciting significant hypoactivity within the B or E time interval in 
the 24 hpf behavioral data, the relative risk (RR) was estimated for 
each 5 dpf developmental endpoint. The plots show the estimated RR 
(solid square) and 95 % confidence intervals. For each plot, the verti-
cal line indicates a RR = 1 (i.e., no evidence of association). The 24 
hpf behavioral and 5 dpf developmental profiles atop the plots are for 
the chemical thiram
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response of chemical-exposed embryos can provide a holis-
tic sensor, unachievable through focused cell-based sys-
tems or singular morphological phenotypic assessments. 
This is of significant value in a screening context employ-
ing a comprehensive suite of endpoints, where certain 
chemical-elicited responses may not manifest in strictly 
morphological changes observed at any single time point. 
Even without a specific mode of action linked to each 24 
hpf behavioral positive chemical, aberrant behavior in an 
otherwise stereotypical response should be cause for addi-
tional scrutiny and may eventually refine existing AOPs or 
elucidate entire new pathways.
These results demonstrate that chemicals altering behav-
ioral responses at an early time point (24 hpf) can mani-
fest in later (5 dpf) developmental abnormalities, indicating 
that rapid behavioral screening can be a useful diagnostic. 
Moreover, chemicals associated with severe behavioral 
abnormalities may lead to developmental effects that are, 
as yet, unmeasured. In these data, we found 102 chemicals 
associated with 24 hpf behavioral endpoints yet no specific 
5 dpf endpoint associations (Supplemental Table 3). These 
chemicals, when encountered at a critical, early exposure 
period, may alter the timing of the coordinated cascade of 
developmental events that normally lead to healthy adults. 
Compared to effects detected by manual, visual inspection 
at 24 hpf, we found that the majority of chemicals inducing 
aberrant behavior were either undetected or not identified 
until higher concentrations. This demonstrates added value 
of the 24 hpf behavior assay in a screening paradigm that 
includes morphological screens as in Truong et al. (2014) 
or end-stage scoring approaches as in Padilla et al. (2012). 
In addition to expanding the net for detection of adverse 
outcomes, combining this early, nondestructive assay with 
later endpoints should reduce false negatives. Given such a 
large, diverse chemical set, false negatives within a particu-
lar assay can arise for any reason, ranging from technical 
handling of chemicals preferentially affecting certain end-
points (especially if measured at different time points) to 
sampling variability within outbred populations. Therefore, 
the combination of evaluating both early behavioral end-
point and phenotypic responses in the same animals pro-
vides the holistic perspective necessary to warrant further 
study of active chemicals.
While measures have been taken to avoid false posi-
tives, the analysis here is tuned toward detection, since the 
goal was to screen a large set of environmental chemicals 
in full concentration–response format. This goal diverges 
from that of compound-similarity clustering approaches 
such as Kokel et al. (2010), because each chemical in our 
set of compounds is (or has been) in commerce and the 
environment. For this reason, they must be characterized 
to determine whether significant evidence of hazard exists 
across a broad concentration range. While our analysis took 
advantage of the magnitude of all data to define expec-
tations and identify outliers, the statistical framework 
described here can accommodate smaller-scale experi-
ments, because activity thresholds are ratio-based compari-
sons to local controls, rather than requiring an absolute unit 
change in spontaneous movement.
The advantages of the statistical framework developed 
here over more traditional alternatives, such as paired sec-
ond-to-second tests, include: (1) ability to detect changes in 
both centrality (i.e., average movement) and distributional 
shape; (2) robustness in the face of changing, nonstandard 
distributions in a measurement of a spontaneous pheno-
type; and (3) consistency, in that explicit perturbations (i.e., 
light pulses) define more stable responses than periods of 
only a few seconds within an experimental interval. While 
the time periods could be subdivided into smaller units of 
analysis for fine-scale modeling of particular responses, 
we found that the asynchrony between individual embryo 
wells on a second-to-second time scale overwhelms treat-
ment-associated variability—especially if more than the 
samples comprising the interquartile range are analyzed as 
in the pooled embryo method of (Kokel et al. 2010). How-
ever, when considered across a multi-second experimental 
interval, consistencies arise, and by using all samples to 
characterize the effects of a given chemical, we capture a 
more representative sample of the full variability present in 
the population. Indeed, our analysis shows high reliability 
amongst separately sourced, blinded replicate sets.
Importantly, with such a noninvasive, automated end-
point, perturbations of AOP-associated molecular targets 
could be assessed through morpholino knockdown and/or 
RNA rescue (Andreasen et al. 2006; Franzosa et al. 2013; 
Miller et al. 2014; Reimers et al. 2006; Tilton et al. 2006; 
Tilton and Tanguay 2008). The scale of the results pre-
sented here, using an experimental design including high 
numbers of biological well-replicates, permits powerful 
enrichment analysis to confirm such molecular targets. We 
have presented integrated analyses spanning endpoints via 
follow-up within our experiment (24 hpf behavior to 5 dpf 
morphology) and external experiments (biochemical assays 
from Sipes et al.). This demonstrates that these results can 
augment the value of systematic data generated by ongo-
ing efforts to realize the promise of modernized, sustain-
able approaches to environmental health protection as 
envisaged by the US National Research Council’s Toxicity 
testing in the 21st century: a vision and a strategy (2007). 
Accordingly, we present these rapid throughput, vertebrate 
screening results as an important resource for cross-species 
hazard assessment and encourage the use of these data for 
additional meta- and cross-platform analyses.
In conclusion, this rapid neurobehavioral assay identi-
fied chemicals displaying light-dependent and light-inde-
pendent effects at an early developmental stage (24 hpf), 
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predicted increased risk of later (5 dpf) developmental 
hazard, associated behavioral responses with in vitro end-
points targeting specific biological pathways, characterized 
a broad concentration–response profile for each chemical, 
and detected chemicals covering several potential modes 
of action. The experiments described here address statisti-
cal uncertainty concerns commonly associated with in vivo 
methods—such as low sample size and inadequate con-
centration–response—by engineering an efficient, rapid 
throughput system where these important design factors 
can be efficiently optimized. This system represents an effi-
cient experimental platform for conducting neurobehavio-
ral assessment early in vertebrate development that, due to 
its noninvasive nature, can be recombined with other exper-
imental interventions and/or later outcome measures.
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